Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inogen Inc (NASDAQ:INGN)

43.15
Delayed Data
As of Jul 30
 +1.35 / +3.23%
Today’s Change
17.72
Today|||52-Week Range
45.75
+37.55%
Year-to-Date

Today’s Trading

Previous close41.80
Today’s open43.27
Day’s range-- - --
Volume504,975
Average volume (3 months)220,120
Market cap$806.0M
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)+36.68%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+49.17%
P/E ratio105.7
Price/Sales5.03
Price/Book6.74

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc-0.41-1.37%
ATRCAtriCure Inc-0.09-0.34%
LMNXLuminex Corp-0.14-0.81%
ATRIAtrion Corp+9.78+2.48%
Data as of 07/30/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)$0.14
Annual revenue (last year)$112.5M
Annual profit (last year)$6.3M
Net profit margin5.56%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Raymond O. Huggenberger
Executive Vice President-
Operations
Matthew S. Scribner
Corporate headquarters
Goleta, California

Forecasts